Close

Loxo Oncology (LOXO) Tops Q1 EPS by 60c, Beats on Revenues

May 8, 2018 6:49 AM EDT

Loxo Oncology (NASDAQ: LOXO) reported Q1 EPS of ($0.12), $0.60 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $38.43 million versus the consensus estimate of $16.46 million.

For earnings history and earnings-related data on Loxo Oncology (LOXO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings